Ina Nordman

561 citations
18 papers · 359 indexed · h-index 6
Topics
Polyomavirus and related diseases (3 papers)Chemotherapy-induced cardiotoxicity and mitigation (3 papers)Lung Cancer Treatments and Mutations (3 papers)

In The Last Decade

Ina Nordman

16 papers receiving 355 citations

Peers

Ina Nordman
Comparison fields: 5 of 63
  • Oncology 259
  • Pulmonary and Respiratory Medicine 110
  • Cancer Research 69
  • Epidemiology 49
  • Immunology 38
Replace Srujitha Murukutla with:
Srujitha Murukutla United States
Jiehui Zhong China
E Procaccini Italy
Ahmet Küçük Türkiye
Ahmet Demirkazık Türkiye
Ken Miwa Japan
Cheuk Hong Leung United States
Agustín Seoane Spain
Motohiko Tokuhisa Japan
Francisco Zambrana Spain
Ina Nordman relative to Srujitha Murukutla United States Srujitha Murukutla's profile →
Citations per field
00.5×4.2×
Srujitha Murukutla · 1×
Citations per year

Countries citing papers authored by Ina Nordman

Since Specialization
Citations

This map shows the geographic impact of Ina Nordman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Nordman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Nordman more than expected).

Fields of papers citing papers by Ina Nordman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Nordman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Nordman. The network helps show where Ina Nordman may publish in the future.

Co-authorship network of co-authors of Ina Nordman

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Nordman. A scholar is included among the top collaborators of Ina Nordman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Nordman. Ina Nordman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 14
3 2
4 10
5 3
6 1
7 5
8 0
9 20
10 2
11 3
12 10
13 262
14 5
15 3
16 0
17 13
18 5

About Ina Nordman

Ina Nordman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 359 indexed citations. Recurring topics across this work include Polyomavirus and related diseases (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (259 citations), Cancer Research (69 citations) and Pulmonary and Respiratory Medicine (110 citations). Ina Nordman has collaborated with scholars based in Australia, France and United States. Frequent co-authors include Hiren Mandaliya, Christopher Oldmeadow, Mark Jones, Aaron L. Sverdlov, D. Ngo, Huy Tran, Tony Bonaventura, Janette L. Vardy, James Lynam and Leonard Kritharides. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026